HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders

Hepatology

Volumn 24, Issue 6, 1996, Pages 1338-1341

  Congia, Mauro ^a   Clemente, Maria Grazia ^a   Dessi, Carlo ^a   Cucca, Francesco ^a   Mazzoleni, Anna Paola ^a   Frau, Fulvia ^a   Lampis, Rosanna ^a   Cao, Antonio ^b   Lai, Maria Eliana ^a   De Virgiliis, Stefano ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COMPLEMENT; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; RHEUMATOID FACTOR; SMOOTH MUSCLE ANTIBODY;

ADOLESCENT; ADULT; ARTHRITIS; ARTICLE; BLOOD TRANSFUSION; CHILD; CHRONIC HEPATITIS; CLINICAL FEATURE; CONTROLLED STUDY; CRYOGLOBULINEMIA; HEPATITIS C VIRUS; HEPATITIS NON A NON B; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEINURIA; PURPURA; THALASSEMIA MAJOR;

EID: 16144362422     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008938157     Document Type: Article

References (35)

1. Zeldis JB, Jensen P. Hepatitis C virus pathogenicity: the corner pieces of the jigsaw puzzle are found. Gastroenterology 1994;106:1118-1120.
2. Shimizu YK, Hijikata M, Iwamoto A, Purcell R, Yoshikura H. Physical and biological properties of HCV inocula useful markers for prediction of vivo infectivity [Abstract]. Tokyo, Japan: International symposium on viral hepatitis and liver disease (May 10-14, 1993): 57.
3. Hijikata M, Shimizu Y, Kato H, Iwamoto A, Shih JW, Alter HJ, Purcell RH, et al. Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol 1993;67:1953-1958.
4. Dammacco F, Sansonno D. Antibodies to hepatitis C virus in Essential mixed cryoglobulinaemia. Clin Exp Immunol 1992;87:352-356.
5. Ferri C, Longombardo G, La Civita L, Greco P, Lombardini P, Cechetti R, Cagianelli MA, et al. Hepatitis C virus chronic infection as a common cause of mixed cryoglobulinemia and autoimmune liver disease. J Intern Med 1994;236:31-36.
6. Lenzi M, Johnson PJ, McFarlane IG, Ballardini G, Smith HM, McFarlane BM, Bridger C, et al. Antibodies to hepatitis C virus in auto-immune liver disease: evidence for geographical heterogeneity. Lancet 1991;338:277-280.
7. Pateron D, Mal F, Callard P, Beaugrand M. Lymphocytic sialoadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992;339:321-323.
8. Johnson JR, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993;328:465-470.
9. Deny P, Bonacorsi S, Guillevin L, Quint L. Association between hepatitis C virus and Polyarteritis nodosa. Clin Exp Rheumatol 1992;10:319-324.
10. Pawlotsky JM, Deforges L, Bretagne S, Andre C, Métreau JM, Thiers V, Zafrani ES, et al. Hepatitis C virus can mimic type 1 (antinuclear antibody positive) autoimmune chronic active hepatitis. Gut 1993;S66-S68.
11. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, Grippon P, et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994;106:1291-1300.
12. Mishito S, Hoshi Y, Takeda K, Yoshikawa A, Gotanda T, Takahashi K, Akahane Y, et al. Non-A non-B hepatitis specific antibodies directed a host derived epitope: implication for an auto-immune process. Lancet 1990; 336:1400-1403.
13. Michel G, Ritter A, Gerken G, Meyer Zum Buschenfelde KH, Decker R, Manns MP. Anti-GOR and hepatitis C virus in autoimmune liver disease. Lancet 1992;339:267-269.
14. Lunel F. Hepatitis C virus and autoimmunity: fortuitous association or reality? Gastroenterology 1994;107:1550-1555.
15. Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J, Ben Yahia M, Andrè C, Voisin MC, et al. Extrahepatic immunologic manifestation in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995; 122:169-173.
16. De Virgiliis S, Fiorelli G, Fargion S, Cornacchia G, Sanna G, Cossu P, Murgia V, et al. Chronic liver disease in transfusion-dependent thalassaemia: hepatitis B virus marker studies. J Clin Pathol 1980;33:949-953.
17. Lai ME, Mazzoleni AP, Argiolu F, De Virgiliis S, Balestrieri A, Purcell R, Cao A, et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 1994;343:388-390.
18. Contu L, Arras M, Mulargia M, La Nasa G, Carcassi C, Leone AL, Ledda A, et al. Study of HLA segregation in 479 thalassemic families. Tissue Antigens 1992;39:58-67.
19. Cucca F, Lampis R, Frau F, Macis D, Angius E, Masile P, Chessa M, et al. The distribution of DR4 haplotypes in Sardinia suggests a primary association of type 1 diabetes with DRB1 and DQB1 loci. Hum Immunol 1995;43:301-308.
20. Rosatelli MC, Dazy A, Faa V, Meloni A, Sardu R, Saba L, Kan YW, et al. Molecular characterization of β-thalassemia in Sardinian polulation. American J Hum Genet 1992;50:422-426.
21. Cianciulli P, Sollecito D, Sorrentino F, Forte L, Gilardi E, Massa A, Papa G, et al. Early detection of nephrotoxic effects in thalassemic patients receiving desferrioxamine therapy. Kidney Internat 1994;46:467-470.
22. Desmet VJ, Gerber M, Hoofnagle J, Manns MP, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. HEPATOLOGY 1994; 19:1513-1520.
23. Lai ME, Mazzoleni AP, Farci P, Melis A, Porru A, Orgiana G, Arnone M, et al. Markers of hepatitis C virus infection in Sardinian blood donors: relationship with alanine aminotransferasE levels. J Med Virol 1993;41: 282-288.
24. Higuchi R. Simple and rapid preparation of samples for PCR. In: Erlich HA, ed. PCR techonology: principle and application for DNA amplification. New York: Stockton, 1989:31.
25. Bugawan TL, Erlich H. Rapid tying of HLA-DQB1 DNA polymorphism using non-radioactive oligonucleotide probes and amplified DNA. Immunogenet 1991;33:163-170.
26. Erlich HA, Bugawan TL. HLA class II gene polymorphism: DNA typing, evolution, and relationship to disease susceptibility. In: Erlich HA, ed. PCR technology: principle and application for DNA amplification. New York: Stockton, 1989:193.
27. Begovich AB, McClure GR, Suraj VC, Helmuth RC, Fildes N, Bugawan TL, Erlich HA, et al. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J Immunol 1992;148:249.
28. Congia M, Frau F, Lampis R, Frau R, Mele R, Cucca F, Muntoni F, et al. A high frequency of the A30, B18, DR3, DRw52, DQw2 extended haplotype in Sardinian celiac disease patients: further evidence that disease susceptibility is conferred by DQA1*0501, B1*0201. Tissue Antigens 1992;39:78.
29. Kim JP, Linnen J, Wages J, Fry K, Zhang-Keck ZY, Young L, Gallagher P, et al. Hepatitis G virus (HGV), a new hepatitis virus associated with human hepatitis. J Hepatol 1995;23(suppl 1):78A.
30. Almarri A, Batchelor JR. HLA and hepatitis B infection. Lancet 1994; 344: 1194-1195.
31. Thursz MR, Kwiatkowski D, Allsopp CEM, Greenwood BM, Thomas HC, Hill AVS. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995;322:1065-1069.
32. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology 1995; 108:157-164.
33. Apple RJ, Erlich HA, Klitz W, Manos MM, Becker TM, Wheeler CM. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet 1994;6:157-162.
34. Itescu S, Rose S, Dwyer E, Winchester R. Certain HLA-DR5 and -DR6 major histocompatibility complex class II alleles are associated with a CD8 lymphocytic host response to human immunodeficiency virus type 1 characterized by low lymphocyte viral strain heterogeneity and slow disease progression. Proc Natl Acad Sci U S A 1994;91:11472-11476.
35. Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, Zilio P, et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994;330:750-756.